Keyphrases
Antibiotics
14%
BlaZ
9%
CA-MRSA
45%
Cefazolin Inoculum Effect
12%
Children's Hospital
11%
Clinical Outcomes
13%
Community-associated
22%
Community-onset
22%
COVID-19
18%
COVID-19 Testing
10%
Decolonization
39%
Environmental Surfaces
14%
Household Contacts
16%
Householder
14%
Infection Prevention
17%
Infections in children
20%
Infectious Diseases
8%
Infectious Diseases Consultation
20%
K-12
16%
K-12 Students
8%
Methicillin Resistance
18%
Methicillin-resistant S. Aureus
51%
Methicillin-resistant Staphylococcus Aureus
76%
Methicillin-resistant Staphylococcus Aureus Infection
10%
Missouri
22%
Mitigation Strategies
9%
Molecular Epidemiology
15%
Mupirocin
13%
Nasal Colonization
8%
Neonatal Intensive Care Unit
16%
Odds Ratio
8%
Prevention Practices
16%
Prevention Strategies
9%
Randomized Trial
9%
Recurrent Infection
8%
S. Aureus Colonization
16%
S. Aureus Infection
15%
SARS-CoV-2 Transmission
12%
School-based
9%
Skin Infection
18%
Skin Tissue
80%
Soft Tissue Infection
80%
St. Louis
21%
Staphylococcal Infections
24%
Staphylococcus Aureus
100%
Staphylococcus Aureus Colonization
23%
Strain Typing
15%
Telemedicine
20%
Transmission Events
8%
Trimethoprim-sulfamethoxazole (TMP-SMX)
11%
Medicine and Dentistry
Abscess
9%
Antibiotics
14%
Antiinfective Agent
10%
Bloodstream Infection
7%
Chlorhexidine
6%
Clinical Trial
5%
Cohort Effect
5%
COVID-19
6%
Emergency Department
5%
Gram Positive Infection
8%
Health Care Cost
6%
Household
9%
Incision and Drainage
7%
Infection
27%
Infectious Disease
22%
Infectious Disease Treatment
8%
Methicillin Resistant Staphylococcus Aureus
24%
Methicillin Resistant Staphylococcus Aureus Infection
8%
Meticillin
5%
Outpatient
5%
Pediatric Infection
9%
Pediatrics
7%
Pediatrics Patient
5%
Pseudomonic Acid
9%
Recurrent Disease
5%
Recurrent Infection
6%
Severe Acute Respiratory Syndrome Coronavirus 2
8%
Skin Abscess
8%
Skin Infection
15%
Soft Tissue Infection
38%
Staphylococcal Bacteremia
8%
Staphylococcus Aureus
39%
Staphylococcus Infection
10%
Systematic Review
8%
Telemedicine
20%
Trimethoprim/Sulfamethoxazole
10%